Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.25
Bid: 34.25
Ask: 35.45
Change: -1.075 (-2.99%)
Spread: 1.20 (3.504%)
Open: 36.00
High: 36.00
Low: 34.00
Prev. Close: 35.925
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

Thu, 04th Mar 2021 19:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Workspace Group PLC - London-based provider of service offices - Prices its first green bond, a sterling-denominated senior unsecured guaranteed green bond issuance of GBP300 million and for a term of seven years. The bonds will bear interest at a rate of 2.25% per annum. "This follows a series of fixed income investor meetings which generated strong institutional demand," company adds. Following the issue of the bonds, the company's weighted average debt facility maturity will increase from 3.9 years to 4.9 years and its weighted average cost of debt will reduce to 3.6% on a pro forma basis.

----------

Pure Gold Mining Inc - Canadian gold miner - Say surface exploration drilling has intersected high grade gold mineralization located outside company's existing mineral resources at three distinct targets: Wedge, Treasure Box, and No 1 Vein. "The continued success of the ongoing surface exploration program is consistent with the company's objective of fuelling PureGold's future organic growth beyond the Phase 1 mine by discovering new zones and expanding upon known zones of high grade gold across the company's 47 square kilometre property," company adds.

----------

Arrow Global Group PLC - buyer of debt from banks, credit card companies and telecommunications businesses - Creates Clients & Capital Formation Group within its Arrow Capital Management business. "The Clients & Capital Formation Group will partner with Arrow's clients to provide differentiated investment solutions and world-class insights from Arrow's core areas of expertise in European non-performing and non-core debt," company explains. It adds: "The group will be responsible for setting Arrow's Capital Formation strategy and broadening the firm's investor set by enabling global capital pools to access the opportunities presented by the European NPL market through Arrow Capital Management." Appoints longtime Citigroup Inc insider Kamran Anwar to run new unit.

----------

Angle PLC - Guildford-based liquid biopsy company - US Food & Drug Administration asks for additional information for company's submission requesting De Novo clearance of the Parsortix PC1 system. "Receipt of an AIR was expected and is in line with typical De Novo clearance processes. Angle is confident of being able to provide a full response to all the information requests raised," company says. It says FDA indicates its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Company adds: "Some of the technical information requested necessitates some targeted additional analytical studies. However, these additional analytical studies do not require patient samples and Angle anticipates that the necessary studies, which are already at an advanced planning stage, can be completed and the response submitted by early May."

----------

Countrywide PLC - estate agent - Says UK High Court of Justice sanctions its acquisition by Connells. The court sanction follows UK Financial Conduct Authority approving the deal. Expects shares to cancelled on March 9. Countrywide at the end of 2020 agreed to an offer by Connells of 395 pence per share, valuing the company at GBP223.1 million.

----------

Futura Medical PLC - Surrey-based pharmaceutical company - Enters into certain financing transactions with HT Riverwood Multi-Growth Fund, a fund managed by Atlantis Investment Management Ltd, which provides the company with up to GBP2 million in cash. Notes GPB1.5 million of which has been received. Also, company enters licensing agreement with Pride Century Ventures, a special purpose vehicle owned by Co-High Investment Management Ltd for the rights to exclusively develop and commercialise the company's gel-based erectile dysfunction treatment MED3000, in China and South East Asia. Co-High will provide funding currently estimated to be up to GBP4 million for development and regulatory approval of MED3000 in the region and Futura will be entitled to 50% of regional profits.

----------

Frontier IP Group PLC - UK-based intellectual property commercialisation firm - Investee Exscientia Ltd completes USD100 million Series C funding round with BlackRock funds. As a result of the financing round, Frontier IP now holds a 2.1% equity stake in Exscientia. "Based on the group's overall trading for the year to date and the outlook for the remainder of the financial year, the board remains confident on the prospects for the year ended June 30 2021," company adds. Interim results, for six months to December 31, due on March 24.

----------

Empyrean Energy PLC - oil and gas explorer with interests in China, Indonesia and US - Notes it expects tax refund in the US of USD357,702 to be received during March. Its tax advisors recently submitted the company's federal tax return with the US Internal Revenue Service for financial year 2020, ended March 31.

----------

Crossword Cybersecurity PLC - Richmond, England-based cyber security and risk-focused technology commercialisation company - Says The IASME Consortium Ltd, the UK government cyber essentials partner, has selected Rizikon Assurance as the core platform to support a new counter fraud fundamentals certification which has received government funding. Rizikon Assurance, the company's leading product, is a SaaS platform that enables medium to large companies to assess and manage all risks from their suppliers. Chief Executive Tom Ilube says: "It is excellent news to be able to support IASME once again, with the roll out of another innovative certification programme. The Counter Fraud Fundamentals certification will help give customers confidence when choosing a provider, that they are well protected against fraud. Supporting this certification will also further strengthen our excellent relationship with IASME."

----------

UK Oil & Gas PLC - oil & gas exploration and production company based in London - Says appeal against Surrey County council's refusal of planning consent for the Loxley gas project, located in licence PEDL234, will now be heard at a public inquiry to commence on July 27, 2021. Recently lodged appeal with the planning inspectorate against Surrey County Council's decision in December to refuse planning consent for the Loxley gas appraisal project. Says leading counsel advises there are strong grounds to expect a positive appeal outcome as the council's cited reasons for refusal are in direct conflict with the advice of its professional planning and highway officers and their approval recommendations. Expects a decision by the end of 2021.

----------

Katoro Gold PLC - gold and nickel exploration and development company - Notes confirmatory metallurgical test work completed at Blyvoor gold tailings project and says "extremely pleased" with results. Tests were delayed due to pandemic. "The metallurgical test results, as expected, confirmed the findings of the CPR but also identified optimization opportunities related to metallurgical processing that could improve gold recoveries," company says. It adds: "Funding negotiations continued and progressed well in the interim and can now move towards finalization and conclusion, after receipt of the metallurgical test results confirming the positive findings of the CPR."

----------

Tower Resources PLC - Africa-focused oil and gas company - Extends loan facility of USD750,000. The Facility is provided by the company's shareholder Pegasus Petroleum Ltd whose ultimate beneficial owner is the company's chair & chief executive, Jeremy Asher, and was originally provided to the company as a bridging loan. The facility has now been extended to the end of November 2021, though the company hopes to repay it by July 15, 2021, in which case the cost of the extension will reflect the earlier repayment.

----------

Boston International Holdings PLC - special purpose acquisitions company - Terminates intended acquisition of Alexanders Discount Ltd, an invoice factoring company based in southeast England. It adds: "The company will continue its search for acquisition opportunities, as outlined in the company's prospectus published in October 2016. It is expected that the company's ordinary shares will resume trading on the Main Market of the London Stock Exchange in due course following consultation with the UK Financial Conduct Authority and completion of a fundraise. In the meantime, they remain suspended from trading."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 15:10

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
13 May 2014 12:38

Futura Confident In Future, Gearing For Product Launches

LONDON (Alliance News) - Futura Medical PLC expressed confidence for its future, saying that by the end of 2014 two of its products are set to generate recurring revenues, in a statement ahead of its annual general meeting Tuesday. The biotechnology company said it is focused on driving pro

Read more
28 Mar 2014 10:28

Futura Medical Loss Widens As It Ramps Up For "Landmark" 2014

LONDON (Alliance News) - Futura Medical PLC expressed confidence for a "landmark" 2014 Friday, after it posted a wider loss in 2013 as it ramped up development of its product portfolio. The company posted a pretax loss of GBP2.52 million, widened slightly from GBP2.44 million in 2012, as a

Read more
10 Mar 2014 11:43

Futura Medical Says Condom To Be Launched In Several Countries In 2014

LONDON (Alliance News) - Futura Medical PLC Monday said it expects to launch its CSD500 condom in several countries in the second half of this year, including one launch using its own brand name, a rollout that will continue into 2015 and beyond. The biotechnology company has developed the

Read more
10 Mar 2014 08:26

UK MORNING BRIEFING: Shares Gain; Fyffes To Merge With Chiquita

LONDON (Alliance News) - Shares have opened higher Monday despite a weak lead from Asia.

M&A and share placings have grabbed attention at the open.

Chiquita Brands International Inc and Fyffes PLC said they will merge to create the world's largest ba

Read more
7 Mar 2014 18:16

Futura Medical Raises GBP12 Million In Share Placing

LONDON (Alliance News) - Futura Medical PLC Friday said it has raised GBP12.0 million through the conditional placing of 21.1 million shares in the company at a price of 57 pence per share. The healthcare company said it placed the shares with existing and new institutional investors and sa

Read more
27 Jan 2014 11:45

Futura In Talks With Commercial Partners As PET500 Product Launches In US

LONDON (Alliance News) - Futura Medical PLC said Monday it is continuing discussions with potential commercial partners ahead of the launch of its new CSD500 condom, as Ansell Ltd began the roll out of its PET500 product for premature ejaculation in the US. Ansell has exclusive worldwide ri

Read more
17 Jan 2014 16:54

Tesco Chairman keeps the faith after recent poor update

Tesco Non-Executive Chairman Sir Richard Broadbent added 10,000 shares to his stake, the supermarket chain announced Friday. Broadbent, who joined the board in July 2011, bought the shares at 331.22p a piece for a total spend of £33,122. The purchase was made less than a week after the company p

Read more
14 Jan 2014 15:22

Sector movers: AstraZeneca, Shire lift pharma stocks on upbeat guidance

Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks. At the JP Morgan Healthcare Conference in San Francisco, AstraZeneca Chief Executive Pascal Soriot said he expects the company to return to growth sooner than analysts c

Read more
17 Oct 2013 09:34

Futura Medical Gets European Marketing Approval For Novel Condom

Read more
24 Sep 2013 16:44

Regenersis CFO tops up stake as results impress

Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th. Dhody bought the shares a price of 255p per share, spending a total o

Read more
12 Sep 2013 10:46

Futura Medical Narrows Losses As New Condom Gets European Licences

Read more
12 Sep 2013 10:27

Futura Medical losses shrink as launch climax approaches - UPDATE

Losses contracted slightly at condom developer Futura Medical in the first half-year, as it continued to massage the costs of bringing its lead product towards the climax of market launch in 2014. Losses before tax shrank from £1.08m to £1.03m, as a net cash outflow of £0.7m saw the AIM company ho

Read more
9 Sep 2013 11:37

UK Winners & Losers: BG Down 5%, CSR Up 5%; Mediazest Drops 21%

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.